| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
SSgA SPDR ETFs Europe II Public Limited Company - SPDR S&P U.S. Health Care Select Sector UCITS ETF Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$39.32 |
| 52 Week High | US$41.47 |
| 52 Week Low | US$34.53 |
| Beta | 0 |
| 1 Month Change | -3.19% |
| 3 Month Change | 1.89% |
| 1 Year Change | 10.83% |
| 3 Year Change | 35.34% |
| 5 Year Change | 76.44% |
| Change since IPO | 77.53% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| SXLV | NL Capital Markets | NL Market | |
|---|---|---|---|
| 7D | 0.005% | -6.0% | -0.1% |
| 1Y | 10.8% | 1.6% | 16.2% |
Return vs Industry: SXLV exceeded the Dutch Capital Markets industry which returned 1.2% over the past year.
Return vs Market: SXLV underperformed the Dutch Market which returned 18% over the past year.
Price Volatility
| SXLV volatility | |
|---|---|
| SXLV Average Weekly Movement | 1.5% |
| Capital Markets Industry Average Movement | 3.5% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in NL Market | 7.9% |
| 10% least volatile stocks in NL Market | 2.2% |
Stable Share Price: SXLV has not had significant price volatility in the past 3 months.
Volatility Over Time: SXLV's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | n/a | ie.spdrs.com/en/professional/etf/spdr-sp-us-health-care-select-sector-ucits-etf-ZPDH-GY |
SSgA SPDR ETFs Europe II Public Limited Company - SPDR S&P U.S. Health Care Select Sector UCITS ETF is an exchange traded fund launched and managed by State Street Global Advisors Limited. It is co-managed by State Street Global Advisors, Inc. The fund invests in the public equity markets of the United States.
SSgA SPDR ETFs Europe II Public Limited Company - SPDR S&P U.S. Health Care Select Sector UCITS ETF Fundamentals Summary
| SXLV fundamental statistics | |
|---|---|
| Market cap | €349.60m |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs SXLV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SXLV income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did SXLV perform over the long term?
See historical performance and comparison